EUCTR2005-001722-92-AT进行中（未招募）不适用
Systemic Bevacizumab (Avastin®) Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study) - BEAT-AMD-Study
The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery0 个研究点目标入组 30 人开始时间: 2005年10月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •AMD patients with fibrovascular pigment epithelium detachment (PED), subfoveal choroidal neovascularisations (CNV) extending under the geometric center of the foveal avascular zone, and a central retinal thickness of at least 300 microns.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients who had arterial thromboembolic diseases
- •Patients with: Cancer, proteinuria, renal impairment, hepatic dysfunction, vision threatening ophthalmic diseases other than AMD
研究者
相似试验
已完成
2 期
Bevacizumab treatment of intra-venous administration and diagnostic nuclear medicine for symptomatic radiation necrosis in the braiJPRN-UMIN000005391Department of Neurosurgery, Osaka Medical College40
进行中（未招募）
不适用
Efficacy of intravitreal bevacizumab for exudative age-related macular degeneration. - ARMAVAExudative age-related macular degenerationMedDRA version: 12.1Level: LLTClassification code 10015902Term: Exudative senile macular degeneration of retinaEUCTR2009-016158-42-IT.L.S.S. 16
进行中（未招募）
不适用
Bevacizumab (Avastin®) as inhibitor of collateral tumor vessel growth during transarterial chemoembolisation (TACE) for Hepatocellular Carcinoma (HCC): a pilot trial - AVATACE-1Hepatocellular CarcinomaEUCTR2004-004963-32-ATniv. Prof. Dr. Markus Peck-Radosavljevic40
已完成
2 期
A Phase II Study of Bevacizumab (Avastin®) in Combination with Standard Second line chemotherapy (Docetaxel Or Pemetrexed) in Patients with Non-Squamous Non-Small-Cell Lung Cancer previously Treated with chemotherapyon-sq NSCLC with previously treatedJPRN-UMIN000007123Hiroshima University Hospital Respiratory medicine34
进行中（未招募）
不适用
Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration - NDViasual acuity lossMedDRA version: 9.1Level: SOCClassification code 10015919Term: Eye disordersEUCTR2006-004320-36-ITAZIENDA OSPEDALIERA SENESE